Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $4.03 Million - $5.3 Million
100,000 New
100,000 $4.15 Million
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $1.82 Million - $2 Million
25,000 New
25,000 $1.93 Million
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $7.8 Million - $11.3 Million
-168,037 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $8.27 Million - $10.8 Million
168,037 New
168,037 $18.2 Million
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $18.3 Million - $21 Million
-305,000 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $18.3 Million - $19.9 Million
305,000
305,000 $18.7 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.